Hanall Biopharma Co., Ltd. (KRX:009420)
South Korea · Delayed Price · Currency is KRW 57,400
+1,200 (2.14%)
At close: Mar 18, 2026
60.56% (1Y)
| Market Cap | 2.91T +46.1% |
| Revenue (ttm) | 155.18B +11.7% |
| Net Income | -5.56B |
| EPS | -109.00 |
| Shares Out | 50.78M |
| PE Ratio | n/a |
| Forward PE | 2,843.67 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 339,355 |
| Average Volume | 435,102 |
| Open | 57,000 |
| Previous Close | 56,200 |
| Day's Range | 55,400 - 57,500 |
| 52-Week Range | 24,000 - 64,000 |
| Beta | 0.90 |
| RSI | 53.82 |
| Earnings Date | May 13, 2026 |